Charles Schwab Investment Management Inc Theravance Biopharma, Inc. Transaction History

Charles Schwab Investment Management Inc

  • $557 Billion
  • Q2 2025

A detailed history of Charles Schwab Investment Management Inc transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 303,887 shares of TBPH stock, worth $4.35 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
303,887
Previous 287,716 5.62%
Holding current value
$4.35 Million
Previous $2.57 Million 30.44%
% of portfolio
0.0%
Previous 0.0%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025
BUY
$8.32 - $11.25 $134,542 - $181,923
16,171 Added 5.62%
303,887 $3.35 Million
Q1 2025

Sep 15, 2025
SELL
$8.44 - $10.47 $136,483 - $169,310
-16,171 Reduced 5.32%
287,716 $2.57 Million
Q1 2025

May 09, 2025
SELL
$8.44 - $10.47 $52,496 - $65,123
-6,220 Reduced 2.12%
287,716 $2.57 Million
Q4 2024

Feb 06, 2025
BUY
$7.93 - $10.08 $16,335 - $20,764
2,060 Added 0.71%
293,936 $2.77 Million
Q3 2024

Nov 12, 2024
BUY
$7.66 - $10.25 $4,672 - $6,252
610 Added 0.21%
291,876 $2.35 Million
Q2 2024

Aug 12, 2024
SELL
$8.29 - $9.92 $159,458 - $190,811
-19,235 Reduced 6.19%
291,266 $2.47 Million
Q1 2024

May 08, 2024
SELL
$8.22 - $11.59 $28,852 - $40,680
-3,510 Reduced 1.12%
310,501 $2.79 Million
Q4 2023

Feb 06, 2024
SELL
$8.58 - $11.4 $121,544 - $161,492
-14,166 Reduced 4.32%
314,011 $3.53 Million
Q3 2023

Nov 08, 2023
SELL
$8.38 - $10.44 $630,863 - $785,944
-75,282 Reduced 18.66%
328,177 $2.83 Million
Q2 2023

Aug 09, 2023
SELL
$10.16 - $11.92 $806,836 - $946,602
-79,413 Reduced 16.45%
403,459 $4.18 Million
Q1 2023

May 11, 2023
SELL
$9.87 - $11.44 $330,802 - $383,423
-33,516 Reduced 6.49%
482,872 $5.24 Million
Q4 2022

Feb 13, 2023
SELL
$9.65 - $11.34 $82,295 - $96,707
-8,528 Reduced 1.62%
516,388 $5.79 Million
Q3 2022

Nov 14, 2022
BUY
$8.39 - $10.22 $179,873 - $219,106
21,439 Added 4.26%
524,916 $5.32 Million
Q2 2022

Aug 15, 2022
BUY
$8.41 - $10.34 $848,039 - $1.04 Million
100,837 Added 25.04%
503,477 $4.56 Million
Q1 2022

May 13, 2022
BUY
$8.33 - $12.96 $100,751 - $156,751
12,095 Added 3.1%
402,640 $3.85 Million
Q4 2021

Feb 11, 2022
BUY
$7.42 - $11.05 $287,539 - $428,209
38,752 Added 11.02%
390,545 $4.32 Million
Q3 2021

Nov 16, 2021
SELL
$6.77 - $14.41 $32,164 - $68,461
-4,751 Reduced 1.33%
351,793 $2.6 Million
Q2 2021

Aug 16, 2021
BUY
$14.52 - $22.46 $334,831 - $517,927
23,060 Added 6.91%
356,544 $5.18 Million
Q1 2021

May 17, 2021
BUY
$16.57 - $21.08 $164,142 - $208,818
9,906 Added 3.06%
333,484 $6.81 Million
Q4 2020

Feb 16, 2021
BUY
$14.89 - $20.16 $149,108 - $201,882
10,014 Added 3.19%
323,578 $5.75 Million
Q3 2020

Nov 13, 2020
SELL
$14.79 - $22.49 $9,554 - $14,528
-646 Reduced 0.21%
313,564 $4.64 Million
Q2 2020

Aug 14, 2020
BUY
$20.64 - $30.69 $302,045 - $449,117
14,634 Added 4.88%
314,210 $6.6 Million
Q1 2020

May 15, 2020
BUY
$17.84 - $31.21 $561,531 - $982,365
31,476 Added 11.74%
299,576 $6.92 Million
Q4 2019

Feb 07, 2020
BUY
$16.12 - $25.89 $148,900 - $239,145
9,237 Added 3.57%
268,100 $6.94 Million
Q3 2019

Nov 08, 2019
BUY
$16.51 - $23.78 $113,407 - $163,344
6,869 Added 2.73%
258,863 $5.04 Million
Q2 2019

Aug 09, 2019
BUY
$15.6 - $25.15 $203,455 - $328,006
13,042 Added 5.46%
251,994 $4.12 Million
Q1 2019

May 14, 2019
BUY
$22.57 - $28.15 $91,859 - $114,570
4,070 Added 1.73%
238,952 $5.42 Million
Q4 2018

Feb 14, 2019
SELL
$22.52 - $35.07 $44,544 - $69,368
-1,978 Reduced 0.84%
234,882 $6.01 Million
Q3 2018

Nov 13, 2018
BUY
$22.83 - $32.67 $241,815 - $346,040
10,592 Added 4.68%
236,860 $7.74 Million
Q2 2018

Aug 08, 2018
BUY
$22.06 - $25.52 $379,277 - $438,765
17,193 Added 8.22%
226,268 $5.13 Million
Q1 2018

May 07, 2018
BUY
$23.37 - $29.71 $219,631 - $279,214
9,398 Added 4.71%
209,075 $5.07 Million
Q4 2017

Jan 17, 2018
BUY
$25.82 - $35.66 $209,632 - $289,523
8,119 Added 4.24%
199,677 $5.57 Million
Q3 2017

Nov 13, 2017
BUY
$23.88 - $34.96 $4.57 Million - $6.7 Million
191,558
191,558 $6.56 Million

Others Institutions Holding TBPH

# of Institutions
140
Shares Held
48.7M
Call Options Held
0
Put Options Held
11.6K
View Full List

About Theravance Biopharma, Inc.

TBPH Quotes by TradingView
  • Ticker TBPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,782,400
  • Market Cap $956M
  • Description
  • Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...
More about TBPH
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email